Cystic fibrosis, a genetic disorder, affects lungs and digestion due to thick mucus. Treatments alleviate symptoms, but no cure exists.
Cystic fibrosis affects 30,000 Americans, causing mucus buildup. Early detection and treatment are key, with ongoing research for cures.
New CF drug Kalydeco, targeting a specific genetic mutation, may increase life quality and expectancy for patients, showing early promise.
Cystic fibrosis is a genetic disease causing thick mucus in lungs and digestive issues, often leading to infections and growth impediments.